3Tozaki-Saitoh H, Tsuda M, Miyata H, et al. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury.The Journal of Neuroscience,2008,28(19):4949-4956.
6Romero-Sandoval A, Chai N, Nutile-McMenemy N, et al. A comparison of spinal Ibal and GFAP expression in rodent models of acute and chronic pain. Brain Research , 2008,1219:116-126.
7Semmler J, Gebert U, Eisenhut T, et al. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology,1993, 78(4):520-525.
8Inoue K.The mechanism and control of neuropathic pain.Rinsho Shinkeigaku,2009,49( 11):779-782.
9Mika J, Osikowicz M, Rojewska E,et al. Differential activation of spinal microglial and astroglial ceils in a mouse model of peripheral neuropathic pain. European Journal of Pharmacology,2009, 623(1-3):65-72.
10Mika J, Wawrzczak-Bargiela A, Osikowicz M, et al. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain, Behavior and Immunity,2009,23(1): 75-84.
9BENNETT GJ,XIE YK. A peripheral mononeuropathy in rat that produces disorders of pair, sensation like those seen in man [ J]. Pain,1988,33(1 ) :87 - 107.
10DELEO JA,YEZIERSKI RP. The role of neuroinflammation and neuroimmune activation in persistent pain [ J ]. Pain ,2001 , 74 ( 3 ) : 142 - 151.
